Invention Grant
- Patent Title: Pharmaceutical formulation comprising antibodies which bind colony stimulating factor-1 receptor (CSF1R)
-
Application No.: US15549528Application Date: 2016-02-05
-
Publication No.: US10039826B2Publication Date: 2018-08-07
- Inventor: Michael Joseph Edouard Boonen , Claude Peerboom
- Applicant: UCB Biopharma SPRL
- Applicant Address: BE Brussels
- Assignee: UCB BIOPHARMA SPRL
- Current Assignee: UCB BIOPHARMA SPRL
- Current Assignee Address: BE Brussels
- Agency: Medler Ferro Woodhouse & Mills PLLC
- Priority: EP15154301 20150209
- International Application: PCT/EP2016/052494 WO 20160205
- International Announcement: WO2016/128318 WO 20160818
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61K47/18 ; A61K47/26 ; A61K47/12
Abstract:
The current invention relates to a new pharmaceutical formulation, in particular to a pharmaceutical formulation comprising a protein, more particularly an antibody as an active ingredient.
Public/Granted literature
- US20180028652A1 PHARMACEUTICAL FORMULATION Public/Granted day:2018-02-01
Information query
